- What we do
-
-
Routes of delivery
- Oral
- Nasal
- Pulmonary
- Parenteral
-
Development stage
- Pre-clinical
- Phase I to Phase II
- Phase III - Commercial
Our Approach
- Project Management
-
- About us
-
-
A CDMO like no other
- About Us
- Our Facilities
- Our History
- Awards and Achievements
-
Leadership Expertise
- Executive Leadership Team
- Board of Directors
- Careers
-
-
- Resources
- Events
- Contact
We are experts in oral, nasal and pulmonary delivery – able to support you to Phase I quickly or help you transition into Phase II and scale up to Phase III.
Meet our Chief Scientific Officer, Richard Johnson at BIO Europe to discover more about how we can bring success to your drug development journey.
Venue
Stockholmsmässan
Mässvägen 1, 125 30 Älvsjö, Stockholm, Sweden
Discover more about our integrated CDMO services and expertise in oral, nasal and pulmonary dosage forms.
Whitepaper: Trainsitioning From Phase I to Phase II
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Meet our experts

Dr. Richard Johnson
Chief Scientific Officer & Founder

Dr. Ian Lafferty
Chief Technical Officer

Laura Mason
Director of Pharmaceutical Sciences

Paul Kelsall
Director of Clinical Manufacturing

Helen Gisby
Director of Analytical Services

Matt Chillman
Principal Scientist
Request a meeting
Connect with our experts at BIO Europe and request a meeting to learn more about our integrated CDMO services.